COL2A1
Gene Information
- Official Symbol: COL2A1
- Official Name: collagen type II alpha 1 chain
- Aliases and Previous Symbols: N/A
- Entrez ID: 1280
- UniProt: P02458
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes the alpha-1 chain of type II collagen, a fibrillar collagen found in cartilage and the vitreous humor of the eye. Mutations in this gene are associated with achondrogenesis, chondrodysplasia, early onset familial osteoarthritis, SED congenita, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome type I, and spondyloepimetaphyseal dysplasia Strudwick type. In addition, defects in processing chondrocalcin, a calcium binding protein that is the C-propeptide of this collagen molecule, are also associated with chondrodysplasia. There are two transcripts identified for this gene. [provided by RefSeq, Jul 2008].
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| Collagen |
| VWC |
| COLFI |
GO Terms
| collagen type II trimer |
| anterior head development |
| MHC class II protein binding |
| limb bud formation |
| embryonic skeletal joint morphogenesis |
| platelet-derived growth factor binding |
| embryonic skeletal joint development |
| otic vesicle development |
| proteoglycan binding |
| cartilage condensation |
| notochord development |
| cell aggregation |
| endochondral ossification |
| replacement ossification |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| negative regulation of signal transduction in absence of ligand |
| extracellular matrix structural constituent conferring tensile strength |
| cartilage development involved in endochondral bone morphogenesis |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| collagen fibril organization |
| collagen trimer |
| endochondral bone morphogenesis |
| chondrocyte differentiation |
| basement membrane |
| roof of mouth development |
| proteoglycan metabolic process |
| embryonic skeletal system morphogenesis |
| inner ear morphogenesis |
| negative regulation of extrinsic apoptotic signaling pathway |
| cellular response to BMP stimulus |
| response to BMP |
| bone morphogenesis |
| ear morphogenesis |
| embryonic skeletal system development |
| extracellular matrix structural constituent |
| sensory perception of sound |
| limb morphogenesis |
| appendage morphogenesis |
| regulation of extrinsic apoptotic signaling pathway |
| sensory perception of mechanical stimulus |
| cartilage development |
| appendage development |
| limb development |
| tissue homeostasis |
| inner ear development |
| bone development |
| ear development |
| visual perception |
| connective tissue development |
| sensory perception of light stimulus |
| negative regulation of apoptotic signaling pathway |
| extracellular matrix |
| skeletal system morphogenesis |
| heart morphogenesis |
| sensory organ morphogenesis |
| ossification |
| embryonic organ morphogenesis |
| endoplasmic reticulum lumen |
| multicellular organismal homeostasis |
| extracellular matrix organization |
| anatomical structure homeostasis |
| collagen-containing extracellular matrix |
| glycoprotein metabolic process |
| extracellular structure organization |
| regulation of apoptotic signaling pathway |
| embryonic organ development |
| supramolecular fiber organization |
| skeletal system development |
| cellular response to growth factor stimulus |
| heart development |
| response to growth factor |
| sensory organ development |
| embryonic morphogenesis |
| chordate embryonic development |
| embryo development ending in birth or egg hatching |
| head development |
| tube development |
| circulatory system development |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| negative regulation of programmed cell death |
| animal organ morphogenesis |
| sensory perception |
| embryo development |
| central nervous system development |
| negative regulation of cell death |
| carbohydrate derivative metabolic process |
| identical protein binding |
| epithelium development |
| regulation of immune response |
| cellular response to endogenous stimulus |
| negative regulation of signal transduction |
| negative regulation of cell communication |
| negative regulation of signaling |
| nervous system process |
| response to endogenous stimulus |
| regulation of apoptotic process |
| regulation of programmed cell death |
| extracellular space |
| negative regulation of response to stimulus |
| homeostatic process |
| regulation of immune system process |
| regulation of cell death |
| tissue development |
| protein-containing complex subunit organization |
| extracellular region |
| system process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| DABN 20μM R00 exp17 | -2.39 |
| DABN racemic mixture R03 exp93 | -2.14 |
| Benzoate 20000μM R08 exp456 | -2.08 |
| Etoposide 0.3μM R05 exp199 | -1.93 |
| AICAR 240μM R05 exp211 | -1.81 |
| Actinomycin-D 0.001μM R00 exp3 | -1.77 |
| GSK461364A 0.1μM R03 exp126 | -1.76 |
| RO-3306 3 to 4μM on day4 R04 exp165 | 1.78 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| PSMA6 | 0.564 |
| PRIM1 | 0.551 |
| TCEB3C | 0.547 |
| PSMB4 | 0.532 |
| UPF1 | 0.527 |
| TBC1D3 | 0.525 |
| TICRR | 0.525 |
| TWISTNB | 0.524 |
| UTP3 | 0.524 |
| TCEB3CL | 0.522 |
| TBC1D3F | 0.514 |
| IK | 0.514 |
| TCEB3CL2 | 0.508 |
| C1QTNF9B | 0.502 |
| SLC4A1 | 0.501 |
| RRP7A | 0.497 |
| TBC1D3H | 0.497 |
| CHD4 | 0.496 |
| RPS7 | 0.494 |
| CDC73 | 0.493 |
| CACTIN | 0.493 |
| PSMB2 | 0.492 |
| ZNF830 | 0.492 |
| VPS28 | 0.49 |
| RPL35 | 0.487 |
| RPS2 | 0.485 |
| EXOSC9 | 0.484 |
| TP53TG3C | 0.483 |
| TP53TG3B | 0.483 |
| TP53TG3 | 0.483 |
| POLR2J3 | 0.481 |
| TYMS | 0.481 |
| KRT78 | 0.481 |
| RRN3 | 0.48 |
| PSMC1 | 0.48 |
| TBC1D3G | 0.48 |
| C14orf93 | 0.475 |
| GOLGA8O | 0.472 |
| ORC6 | 0.472 |
| NPIPB5 | 0.472 |
| TSPY1 | 0.469 |
| VASN | 0.469 |
| POLE | 0.467 |
| PAN3 | 0.466 |
| PWP2 | 0.466 |
| TBC1D3C | 0.465 |
| CCDC116 | 0.465 |
| PSMC2 | 0.463 |
| MFSD12 | 0.463 |
| PSMB3 | 0.461 |
| CDCA5 | 0.46 |
| PSMD11 | 0.459 |
| FAM160A1 | 0.459 |
| COPG1 | 0.458 |
| POLA2 | 0.458 |
| TBC1D3K | 0.457 |
| TBC1D3I | 0.457 |
| TBC1D3E | 0.457 |
| TBC1D3L | 0.456 |
| GOLGA6L1 | 0.454 |
| ACSF2 | 0.454 |
| HAP1 | 0.452 |
| LRR1 | 0.451 |
| AAMP | 0.45 |
| CDH24 | 0.45 |
| SLC6A17 | 0.449 |
| OSBP | 0.448 |
| TP53TG3D | 0.448 |
| NARFL | 0.447 |
| WDR75 | 0.446 |
| PAN2 | 0.444 |
| PBXIP1 | 0.443 |
| MKI67IP | 0.442 |
| ATP6V0C | 0.442 |
| CDC45 | 0.442 |
| AKT1S1 | 0.441 |
| PSMA7 | 0.44 |
| PSMD14 | 0.44 |
| POLR1A | 0.44 |
| MADCAM1 | 0.439 |
| CCNA2 | 0.439 |
| ANKLE2 | 0.439 |
| DNTTIP2 | 0.438 |
| PSMC6 | 0.438 |
| CEP192 | 0.438 |
| TIMELESS | 0.438 |
| DTL | 0.437 |
| DDT | 0.437 |
| CGB2 | 0.436 |
| ZFAND5 | 0.436 |
| ANKLE1 | 0.436 |
| CBWD3 | 0.435 |
| KCTD17 | 0.434 |
| POLA1 | 0.432 |
| GOLGA6L3 | 0.432 |
| CBWD6 | 0.432 |
| NPIPB8 | 0.432 |
| DOCK6 | 0.432 |
| COPE | 0.431 |
| DDTL | 0.431 |
| CCDC64B | 0.429 |
| AATF | 0.429 |
| DHX38 | 0.428 |
| COX7A2L | 0.427 |
| AKIRIN2 | 0.427 |
| MYB | 0.426 |
| ABHD8 | 0.426 |
| TSG101 | 0.425 |
| SH3BP1 | 0.425 |
| RPA2 | 0.424 |
| FAM231C | 0.424 |
| FAM231A | 0.424 |
| SAP30BP | 0.424 |
| OR10G3 | 0.424 |
| RPL9 | 0.423 |
| POLR2F | 0.423 |
| RAD51 | 0.423 |
| POLR2D | 0.423 |
| RPL34 | 0.423 |
| PSMB1 | 0.422 |
| PSMA3 | 0.421 |
| EBNA1BP2 | 0.421 |
| NUP133 | 0.421 |
| HIST2H3A | 0.42 |
| CHAF1A | 0.42 |
| HIST2H3C | 0.419 |
| HINFP | 0.419 |
| NFATC4 | 0.418 |
| MYO1H | 0.418 |
| PAF1 | 0.418 |
| PSMD2 | 0.418 |
| CDCA3 | 0.417 |
| FBL | 0.417 |
| ATP6AP1 | 0.416 |
| RRS1 | 0.415 |
| MPHOSPH10 | 0.415 |
| PLK1 | 0.415 |
| RPS12 | 0.415 |
| CDT1 | 0.414 |
| PLXNB3 | 0.413 |
| CTAGE4 | 0.413 |
| LAD1 | 0.413 |
| RBM48 | 0.412 |
| PPM1D | 0.41 |
| ORC1 | 0.41 |
| GOLGA6L4 | 0.409 |
| CBWD5 | 0.409 |
| CRNKL1 | 0.409 |
| RPS5 | 0.409 |
| PSMD3 | 0.409 |
| RPL6 | 0.408 |
| EXOSC5 | 0.408 |
| GID4 | 0.407 |
| UQCRH | 0.406 |
| SMG1 | 0.405 |
| CTAGE9 | 0.405 |
| PARP3 | 0.404 |
| WDR87 | 0.404 |
| GOLGA8R | 0.404 |
| CLN6 | 0.404 |
| RANBP2 | 0.403 |
| PSMD8 | 0.403 |
| TPX2 | 0.403 |
| EXOSC6 | 0.403 |
| NSF | 0.402 |
| PSMD1 | 0.402 |
| ADD2 | 0.402 |
| PSMC5 | 0.402 |
| PDE4DIP | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 1884
- Expression level (log2 read counts): -4.01
Expression Distribution
COL2A1 Expression in NALM6 Cells: -4.01